Anaplastic lymphoma kinase modulators and methods of use
US7872014B2 · kind B2 · utility
5Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2004 |
| Grant date | Jan 18, 2011 |
| Priority date | — |
| Expiry date | Apr 5, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.